.
.
.
*Special thanks goes to Eileen D. for bringing this to our attention.

See bolded Excerpt such as:

Therefore, pursuant to section 319F-3(b) of the Act, I have determined there is a credible risk that the spread of pandemic influenza A viruses and those with pandemic potential and resulting disease does or could constitute a public health emergency.

…and extends through February 28, 2012.

Section 319F-3(a)(4)(A) confers immunity to manufacturers and distributors of the Covered Countermeasure, regardless of the defined population.

…and amended on September 28, 2009 to provide targeted liability protections for pandemic countermeasures to enhance distribution

100226 Sec HHS Sebelius Pandemic Influenza Vaccines Amendment

[Federal Register: March 5, 2010 (Volume 75, Number 43)]
[Notices]
[Page 10268-10272]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr05mr10-76]

=======================================================================
———————————————————————–

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary

Pandemic Influenza Vaccines–Amendment

Authority:  42 U.S.C. 247d-6d.

ACTION: Notice of amendment to the September 28, 2009 Republished
Declaration under the Public Readiness and Emergency Preparedness Act.

———————————————————————–

SUMMARY: Amendment to declaration issued on September 28, 2009 (74 FR
51153) pursuant to section 319F-3 of the Public Health Service Act
(“the Act”)

[[Page 10269]]

(42 U.S.C. 247d-6d) to revise covered countermeasures and extend
effective date and republication of the declaration to reflect the
declaration in its entirety, as amended.

DATES: The amendment of the republished declaration issued on September
28, 2009 is effective as of March 1, 2010.

FOR FURTHER INFORMATION CONTACT: Nicole Lurie, MD, MSPH, Assistant
Secretary for Preparedness and Response, Office of the Secretary,
Department of Health and Human Services, 200 Independence Avenue, SW.,
Washington, DC 20201, Telephone               (202) 205-2882         (202) 205-2882 (this is not a toll-free
number).
HHS Secretary’s Amendment to the September 28, 2009 Republished
Declaration for the Use of the Public Readiness and Emergency
Preparedness Act for H5N1, H2, H6, H7, H9 and 2009-H1N1 Vaccines:
Whereas there are or may be multiple animal influenza A viruses,
circulating in wild birds and/or domestic animals that cause, or have
significant potential to cause, sporadic human infections or have
mutated to cause pandemics in humans;
Whereas, these viruses may evolve into virus strains capable of
causing a pandemic of human influenza because these viruses may cause
infection in and spread among humans and because humans have little or
no immunity to these viruses;
Whereas, one such virus is the 2009 H1N1 Influenza Virus;
Whereas, vaccination may be effective to protect persons from the
threat of pandemic influenza;
Whereas, Secretary Michael O. Leavitt issued a Declaration for the
Use of the Public Readiness and Emergency Preparedness Act dated
January 26, 2007 (“Original Declaration”), as amended on November 30,
2007 and October 17, 2008 with respect to certain avian influenza
viruses;
Whereas, I amended the declaration on June 15, 2009 with respect to
2009 H1N1 influenza virus and on September 28, 2009 to provide targeted
liability protections for pandemic countermeasures to enhance
distribution and to add provisions consistent with other declarations,
and republished the declaration each time in its entirety;
Whereas, the September 28, 2009 declaration extended through
February 28, 2010 for vaccines against influenza virus strains named in
the Declaration other than 2009 H1N1 influenza vaccine;
Whereas, modifications are necessary to revise covered
countermeasures and to extend the effective date of the Declaration;
Whereas, the findings I made in the declaration issued on September
28, 2009 continue to apply;
Whereas, in accordance with section 319F-3(b)(6) of the Act (42
U.S.C. 247d-6d(b)), I have considered the desirability of encouraging
the design, development, clinical testing or investigation,
manufacturing, labeling, distribution, formulation, packaging,
marketing, promotion, sale, purchase, donation, dispensing,
prescribing, administration, licensing, and use of additional covered
countermeasures with respect to the category of disease and population
described in sections II and IV of the September 28, 2009 Republished
Declaration, as hereby amended, and have found it desirable to
encourage such activities for these additional covered countermeasures,
and;
Whereas, to encourage the design, development, clinical testing or
investigation, manufacturing and product formulation, labeling,
distribution, packaging, marketing, promotion, sale, purchase,
donation, dispensing, prescribing, administration, licensing, and use
of medical countermeasures with respect to the category of disease and
population described in sections II and IV of the September 28, 2009
Republished Declaration, as hereby amended, it is advisable, in
accordance with section 319F-3(a) and (b) of the Act, to provide
immunity from liability for covered persons, as that term is defined at
section 319F-3(i)(2) of the Act, and to include as such covered persons
other qualified persons as I have identified in section VI of the
September 28, 2009 Republished Declaration, as amended;
Therefore, pursuant to section 319F-3(b) of the Act, I have
determined that there is a credible risk that the spread of influenza A
viruses with pandemic potential and resulting disease could in the
future constitute a public health emergency and that spread of one of
these viruses (2009 H1N1 Influenza) has caused a disease that
constitutes a public health emergency.
In order to extend the scope of covered countermeasures and to
extend the effective date of the Declaration, the September 28, 2009
Republished Declaration, is hereby amended as follows:
In the title, delete “for H5N1, H2, H6, H7, H9 and 2009 H1N1
Vaccines” and replace with “for Vaccines Against Pandemic Influenza A
Viruses and Those with Pandemic Potential”.
In the recitals, delete the first through the fourth “whereas”
clauses, and insert two new recitals as follows:
Whereas there are or may be multiple animal influenza A viruses
circulating in wild birds and/or domestic animals that cause, or have
significant potential to cause, sporadic human infections or have
mutated to cause pandemics in humans;
Whereas, these viruses may evolve or have evolved into virus
strains capable of causing a pandemic of human influenza because these
viruses may cause infection in, and spread among, humans and because
humans have little or no immunity to these viruses;
In the sixth “whereas” clause, insert “October 1, 2009, and
December 28, 2009” after “July 24, 2009”.
In the “therefore” clause, delete “avian influenza viruses and
resulting disease could in the future constitute a public health
emergency, and that 2009 H1N1 influenza constitutes a public health
emergency” and replace with: “pandemic influenza A viruses and those
with pandemic potential and resulting disease does or could constitute
a public health emergency”.
In section I, first paragraph, delete “the pandemic
countermeasures influenza A H5N1, H2, H6, H7, H9, and 2009 H1N1
vaccines” each time it appears and replace with “vaccines against
pandemic influenza A viruses with pandemic potential”.
In section I, at the end of the second sentence, replace “IX”
with “X”.
In section II, delete “the virus with (1) highly pathogenic avian
influenza A (H5N1, H2, H6, H7, or H9) virus; or (2) 2009 H1N1
influenza” and replace with “animal and/or human influenza A viruses
against which most humans do not have immunity, except those included
in seasonal influenza vaccines and/or covered under the National
Vaccine Injury Compensation Program, that are circulating in wild birds
and/or domestic animals causing or having significant potential to
cause sporadic human infections or have mutated to cause pandemics in
humans”.
In section III, first paragraph, delete in its entirety and replace
with: “The effective period of time of this Declaration commenced as
described in the September 28, 2009 Republished Declaration, and
extends through February 28, 2012.
In section III, second paragraph, delete “; except that with
respect to 2009 H1N1 influenza vaccine, the effective period commences
on June 15, 2009 and extends through March 31, 2013” and replace with
“through February 28, 2012.”
In section III, add to the end of the section as a new paragraph:
“With respect to any covered countermeasure subsequently covered under
the

[[Page 10270]]

National Vaccine Injury Compensation Program, the effective time period
expires immediately upon such coverage.”
In section VIII, insert “and use” after “administration in the
first sentence, delete “the Act’s” from the second sentence and
replace with “this”, and delete “Countermeasure” from the second
sentence and replace with “Countermeasures”.
In section IX, add to the end of the first sentence: “; and
amended on September 28, 2009 to provide targeted liability protections
for pandemic countermeasures to enhance distribution and to add
provisions consistent with other declarations and republished in its
entirety.”
In section X, after the fifth paragraph, insert a new definition as
follows:
Pandemic influenza A viruses and those with pandemic potential:
Animal and/or human influenza A viruses, except those included in
seasonal influenza vaccines and/or covered under the National Vaccine
Injury Compensation Program, that are circulating in wild birds and/or
domestic animals, that cause, or have significant potential to cause,
sporadic or ongoing human infections, or historically have caused
pandemics in humans, or have mutated to cause pandemics in humans, and
for which the majority of the population is immunologically na[iuml]ve.
In Appendix I, title and item 32, add “H7,” after “H6”.
Throughout, insert “National” before “Vaccine Injury
Compensation Fund”.
All other provisions of the June 15, 2009 Republished Declaration
remain in full force.
Republication of HHS Secretary’s September 28, 2009 Republished
Declaration, as Amended, for the Use of the Public Readiness and
Emergency Preparedness Act for Vaccines Against Pandemic Influenza A
Viruses and Those with Pandemic Potential.
To the extent any term of the September 28 Republished Declaration,
as hereby amended, is inconsistent with any provision of this
Republished Declaration, the terms of this Republished Declaration are
controlling.
Whereas there are or may be multiple animal influenza A viruses
circulating in wild birds and/or domestic animals that cause, or have
significant potential to cause, sporadic human infections or have
mutated to cause pandemics in humans;
Whereas, these viruses may evolve or have evolved into virus
strains capable of causing a pandemic of human influenza because these
viruses may cause infection in, and spread among, humans and because
humans have little immunity to these viruses;
Whereas, on April 26, 2009, Acting Secretary Charles E. Johnson
determined under section 319 of the Public Health Service Act, (42
U.S.C. 247d), that a public health emergency exists nationwide
involving the Swine Influenza A virus that affects or has significant
potential to affect the national security (now called “2009-H1N1
influenza”);
Whereas, on July 24, 2009, October 1, 2009, and December 28, 2009 I
renewed the determination by the Acting Secretary that a public health
emergency exists nationwide involving the Swine influenza A virus (now
called “2009-H1N1 influenza virus”);
Whereas, vaccination may be effective to protect persons from the
threat of pandemic influenza;
Whereas, the possibility of governmental program planners obtaining
stockpiles from private sector entities except through voluntary means
such as commercial sale, donation, or deployment would undermine
national preparedness efforts and should be discouraged as provided for
in section 319F-3(b)(2)(E) of the Public Health Service Act (42 U.S.C.
247d-6d(b)) (“the Act”);
Whereas, immunity under section 319F-3(a) of the Act should be
available to governmental program planners for distributions of Covered
Countermeasures obtained voluntarily, such as by (1) donation; (2)
commercial sale; (3) deployment of Covered Countermeasures from Federal
stockpiles; or (4) deployment of donated, purchased, or otherwise
voluntarily obtained Covered Countermeasures from State, local, or
private stockpiles;
Whereas, the extent of immunity under section 319F-3(a) of the Act
afforded to a governmental program planner that obtains Covered
Countermeasures except through voluntary means is not intended to
affect the extent of immunity afforded other covered persons with
respect to such covered countermeasures;
Whereas, to encourage the design, development, clinical testing or
investigation, manufacturing and product formulation, labeling,
distribution, packaging, marketing, promotion, sale, purchase,
donation, dispensing, prescribing, administration, licensing, and use
of medical countermeasures with respect to the category of disease and
population described in section II and IV it is advisable, in
accordance with section 319F-3(a) and (b) of the Act, to provide
immunity from liability for covered persons, as that term is defined at
section 319F-3(i)(2) of the Act, and to include as such covered persons
such other qualified persons as I have identified in section VI;
Whereas, in accordance with section 319F-3(b)(6) of the Public
Health Service Act (42 U.S.C. 247d-6d(b)) (“the Act”), I have
considered the desirability of encouraging the design, development,
clinical testing or investigation, manufacturing and product
formulation, labeling, distribution, packaging, marketing, promotion,
sale, purchase, donation, dispensing, prescribing, administration,
licensing, and use of medical countermeasures with respect to the
category of disease and population described in sections II and IV
below, and have found it desirable to encourage such activities for the
Covered Countermeasures;
Therefore, pursuant to section 319F-3(b) of the Act, I have
determined there is a credible risk that the spread of pandemic
influenza A viruses and those with pandemic potential and resulting
disease does or could constitute a public health emergency.

I. Covered Countermeasures (as Required by Section 319F-3(b)(1) of the
Act)

Covered Countermeasures are defined at section 319F-3(i) of the
Act.
At this time, and in accordance with the provisions contained
herein, I am recommending the manufacture, testing, development,
distribution, dispensing; and, with respect to the category of disease
and population described in sections II and IV, below, the
administration and usage of vaccines against influenza A viruses with
pandemic potential and any associated adjuvants. The immunity specified
in section 319F-3(a) of the Act shall only be in effect with respect
to: (1) Present or future Federal contracts, cooperative agreements,
grants, interagency agreements, or memoranda of understanding for
vaccines against pandemic influenza A viruses with pandemic potential
used and administered in accordance with this declaration, and (2)
activities authorized in accordance with the public health and medical
response of the Authority Having Jurisdiction to prescribe, administer,
deliver, distribute or dispense the pandemic countermeasures following
a declaration of an emergency, as defined in section X below. In
accordance with section 319F-3(b)(2)(E) of the Act, for governmental
program planners, the immunity specified in section 319F-3(a) of the
Act shall be in effect to the extent they obtain Covered
Countermeasures through voluntary

[[Page 10271]]

means of distribution, such as (1) donation; (2) commercial sale; (3)
deployment of Covered Countermeasures from Federal stockpiles; or (4)
deployment of donated, purchased, or otherwise voluntarily obtained
Covered Countermeasures from State, local, or private stockpiles. For
all other covered persons, including other program planners, the
immunity specified in section 319F-3(a) of the Act shall, in accordance
with section 319F-3(b)(2)(E) of the Act, be in effect pursuant to any
means of distribution.
This Declaration shall subsequently refer to the countermeasures
identified above as Covered Countermeasures.
This Declaration shall apply to all Covered Countermeasures
administered or used during the effective time period of the
Declaration.

II. Category of Disease (as Required by Section 319F-3(b)(2)(A) of the
Act)

The category of disease for which I am recommending the
administration or use of the Covered Countermeasures is the threat of
or actual human influenza that results from the infection of humans
following exposure to animal and/or human influenza A viruses, against
which most humans do not have immunity, except those included in
seasonal influenza vaccines and/or covered under the National Vaccine
Injury Compensation Program, that are circulating in wild birds and/or
domestic animals causing or have significant potential to cause
sporadic human infections or have mutated to cause pandemics in humans.

III. Effective Time Period (as Required by Section 319F-3(b)(2)(B) of
the Act)

The effective period of time of this Declaration commenced as
described in the September 28, 2009 Republished Declaration and extends
through February 28, 2012.
With respect to Covered Countermeasures administered and used in
accordance with the public health and medical response of the Authority
Having Jurisdiction, the effective period of time of this Declaration
commences on the date of a declaration of an emergency and lasts
through and includes the final day that the emergency declaration is in
effect including any extensions thereof through February 28, 2012.
With respect to any covered countermeasure subsequently covered
under the National Vaccine Injury Compensation Program, the effective
time period expires immediately upon such coverage.

IV. Population (as Required by Section 319F-3(b)(2)(C) of the Act)

Section 319F-3(a)(4)(A) confers immunity to manufacturers and
distributors of the Covered Countermeasure, regardless of the defined
population.
Section 319F-3(a)(3)(C)(i) confers immunity to covered persons who
could be program planners or qualified persons with respect to the
Covered Countermeasure only if a member of the population specified in
the Declaration administers or uses the Covered Countermeasure and is
in or connected to the geographic location specified in this
Declaration, or the program planner or qualified person reasonably
could have believed that these conditions were met.
The populations specified in this Declaration are the following:
(1) All persons who use a Covered Countermeasure or to whom such a
Covered Countermeasure is administered as an Investigational New Drug
in a human clinical trial conducted directly by the Federal Government,
or pursuant to a contract, grant or cooperative agreement with the
Federal Government; (2) all persons who use a Covered Countermeasure or
to whom such a Countermeasure is administered in a pre-pandemic phase,
as defined below; and/or (3) all persons who use a Covered
Countermeasure, or to whom such a Covered Countermeasure is
administered in a pandemic phase, as defined below.

V. Geographic Area (as Required by Section 319F-3(b)(2)(D) of the Act)

Section 319F-3(a) applies to the administration and use of a
Covered Countermeasure without geographic limitation.

VI. Other Qualified Persons (as Required by Section 319F-3(i)(8)(B) of
the Act)

With regard to the administration or use of a Covered
Countermeasure, Section 319F-3(i)(8)(A) of the Act defines the term
“qualified person” as a licensed individual who is authorized to
prescribe, administer, or dispense the countermeasure under the law of
the State in which such Covered Countermeasure was prescribed,
administered or dispensed. Additional persons who are qualified persons
pursuant to section 319F-3(i)(8)(B) are the following: (1) Any person
authorized in accordance with the public health and medical emergency
response of the Authority Having Jurisdiction to prescribe, administer,
deliver, distribute or dispense Covered Countermeasures, and their
officials, agents, employees, contractors and volunteers, following a
declaration of an emergency, and (2) Any person authorized to
prescribe, administer, or dispense Covered Countermeasures or who is
otherwise authorized under an Emergency Use Authorization.

VII. Additional Time Periods of Coverage After Expiration of
Declaration (as Required by Section 319F-3(b)(3)(B) of the Act)

A. I have determined that, upon expiration of the applicable time
period specified in Section III above, an additional twelve (12) months
is a reasonable period to allow for the manufacturer to arrange for
disposition of the Covered Countermeasure, including the return of such
product to the manufacturer, and for covered persons to take such other
actions as are appropriate to limit the administration or use of the
Covered Countermeasure, and the liability protection of section 319F-
3(a) of the Act shall extend for that period.
B. The Federal Government shall purchase the entire production of
Covered Countermeasures under the contracts specifically listed by
contract number in section I for the stockpile under section 319F-2 of
the Act, and shall be subject to the time-period extension of section
319F-3(b)(3)(C). Production under future contracts for the same vaccine
will also be subject to the time-period extension of section 319F-
3(b)(3)(C).

VIII. Compensation Fund

In addition to conferring immunity to manufacturers, distributors,
and administrators of the Covered Countermeasures, the Act provides
benefits to certain individuals who sustain a covered injury as the
direct result of the administration or use of the Covered
Countermeasure. The Countermeasures Injury Compensation Program (CICP)
within the Health Resources and Services Administration (HRSA)
administers this compensation program. Information about the CICP is
available at               1-888-275-4772         1-888-275-4772 or http://www.hrsa.gov/countermeasurescomp/
default.htm
<http://frwebgate.access.gpo.gov/cgi-bin/leaving.cgi?from=leavingFR.html\
&log=linklog&to=http://www.hrsa.gov/countermeasurescomp/default.htm> .

IX. Amendments

The Declaration for the Use of the Public Readiness and Emergency
Preparedness Act for H5N1 was published on January 26, 2007; amended on
November 30, 2007 to add H7 and H9 vaccines; amended on October 17,
2008 to add H2 and H6 vaccines; amended on June 15, 2009 to add 2009
H1N1 vaccines and

[[Page 10272]]

republished in its entirety; and amended on September 28, 2009 to
provide targeted liability protections for pandemic countermeasures to
enhance distribution and to add provisions consistent with other
declarations and republished in its entirety. This Declaration
incorporates all amendments prior to the date of its publication in the
Federal Register. Any future amendment to this Declaration will be
published in the Federal Register, pursuant to section 319F-2(b)(4) of
the Act.

X. Definitions

For the purpose of this Declaration, including any claim for loss
brought in accordance with section 319F-3 of the PHS Act against any
covered persons defined in the Act or this Declaration, the following
definitions will be used:
Administration of a Covered Countermeasure: As used in section
319F-3(a)(2)(B) of the Act includes, but is not limited to, public and
private delivery, distribution, and dispensing activities relating to
physical administration of the countermeasures to recipients,
management and operation of delivery systems, and management and
operation of distribution and dispensing locations.
Authority Having Jurisdiction: Means the public agency or its
delegate that has legal responsibility and authority for responding to
an incident, based on political or geographical (e.g., city, county,
Tribal, State, or Federal boundary lines) or functional (e.g., law
enforcement, public health) range or sphere of authority.
Covered Persons: As defined at section 319F-3(i)(2) of the Act,
include the United States, manufacturers, distributors, program
planners, and qualified persons. The terms “manufacturer,”
“distributor,” “program planner,” and “qualified person” are
further defined at sections 319F-3(i)(3), (4), (6), and (8) of the Act.
Declaration of Emergency: A declaration by any authorized local,
regional, State, or Federal official of an emergency specific to events
that indicate an immediate need to administer and use pandemic
countermeasures, with the exception of a Federal declaration in support
of an emergency use authorization under section 564 of the FDCA unless
such declaration specifies otherwise.
Pandemic influenza A viruses and those with pandemic potential:
Animal and/or human influenza A viruses, except those included in
seasonal influenza vaccines and/or covered under the National Vaccine
Injury Compensation Program, that are circulating in wild birds and/or
domestic animals, that cause, or have significant potential to cause,
sporadic or ongoing human infections, or historically have caused
pandemics in humans, or have mutated to cause pandemics in humans, and
for which the majority of the population is immunologically na[iuml]ve.
Pandemic Phase: The following stages, as defined in the National
Strategy for Pandemic Influenza: Implementation Plan (Homeland Security
Council, May 2006): (4) First Human Case in North America; and (5)
Spread Throughout United States.
Pre-pandemic Phase: The following stages, as defined in the
National Strategy for Pandemic Influenza: Implementation Plan (Homeland
Security Council, May 2006): (0) New Domestic Animal Outbreak in At-
Risk Country; (1) Suspected Human Outbreak Overseas; (2) Confirmed
Human Outbreak Overseas; and (3) Widespread Human Outbreaks in Multiple
Locations Overseas.

Dated: February 26, 2010.
Kathleen Sebelius,
Secretary.

APPENDIX

I. List of U.S. Government Contracts–Covered H5N1, H2, H6, H7, H9, and
2009-H1N1 Vaccine Contracts

1. HHSN266200400031C
2. HHSN266200400032C
3. HHSN266200300039C
4. HHSN266200400045C
5. HHSN266200205459C
6. HHSN266200205460C
7. HHSN266200205461C
8. HHSN266200205462C
9. HHSN266200205463C
10. HHSN266200205464C
11. HHSN266200205465C
12. HHSN266199905357C
13. HHSN266200300068C
14. HHSN266200005413C
15. HHSO100200600021C (formerly 200200409981)
16. HHSO100200500004C
17. HHSO100200500005I
18. HHSO100200700026I
19. HHSO100200700027I
20. HHSO100200700028I
21. HHSO100200600010C
22. HHSO100200600011C
23. HHSO100200600012C
24. HHSO100200600013C
25. HHSO100200600014C
26. HHSO100200600022C (formerly 200200511758)
27. HHSO100200600023C (formerly 200200410431)
28. CRADA No. AI-0155 NIAID/MedImmune
29. HHSO100200700029C
30. HHSO100200700030C
31. HHSO100200700031C
32. All present, completed and future Government H5N1, H2, H6, H7,
H9, and 2009-H1N1 vaccine contracts not otherwise listed.

[FR Doc. 2010-4644 Filed 3-4-10; 8:45 am]
BILLING CODE P

.
.
.
.
.

National Coalition of Organized Women

From Laboring Women to Labor Unions, We Move as One

www.ProgressiveConvergence.com

From the desk of the Director:

February 10, 2010

S4479, A6702: Health care practitioner may diagnose, treat or prescribe treatment for a sexually transmissible disease for a person under age eighteen without the consent or knowledge of his or her parents or guardians.

A0778: New York adds such recommended vaccination [HPV] to the list of vaccinations required for school entry

“Is it not the parents and families that must spend their lives, and money, as caretakers should a vaccine injury or adverse event occur to their child?  It stands to reason then, that parents should be in on their underage child’s health decisions. After all, they are the ones who will bear the life long burden of an adverse event! Or will they? Should the State bear the cost and burden of rehabilitation and caretaking for a child who has been debilitated by the vaccine or treatment since the parents, legislatively kept in the dark, have, in essence, had their responsibility in this matter eviscerated by the State”?

-Eileen Dannemann, Director, NCOW

We are on very dangerous grounds when the State tries to protect children from the beliefs of their parents and, more so, passes laws to purposefully deceive them.

Although Sen. Krueger stresses ethics and "transparency" in government she evidences, instead, a proclivity for an absence of transparency; a preference for deception; and an intention to facilitate a widening of the gulf between parent and child demonstrating a glaring inattention to the values of honesty and focus on the family.

As honorable as their deepest intention may be, the passage of Sen. Krueger’s and Assembly woman Poulin’s legislations put a green light on indiscriminate sex, specifically on sexual intercourse, amongst the youngest of our adolescents who may perceive being vaccinated as being the same as “safe sex” and freedom from sexual disease, which it certainly is not.

Moreover and perhaps most morally objectionable these legislations amount to the lawful sanctioning of the practice of deception.  This is not the type of education we expect either from our schools or from Albany leadership.

Link to Bill here: http://open.nysenate.gov/openleg/bill/S4779B

S4779B, A6702 not only violates parental rights and responsibility to make healthcare decisions on behalf of their children but these legislations serve as a national signal for the lawful condoning of deception. It occurs to us that condoning “lying” has no place in law and is antithetical to concept of judicial prudence.

A0778 is a mandate to vaccinate every child with a strain specific vaccine that since its inception claims 16,000 adverse events including death, crippling and ruined lives.  It is backed by only spurious short-term studies that continue to prove disastrous. It is a vaccine that its manufacturer claims at best protects against only 2 out of the myriad of strains of HPV. In many cases the HPV vaccine causes debilitating and sometimes crippling lifelong conditions. http://www.medications.com/se/gardasil

Regards,

Eileen Dannemann, Director, NCOW

Ncowmail@gmail.com

--
Regards,

Eileen Dannemann
Standing director, National Coalition of Organized Women (NCOW)
www.ProgressiveConvergence.com
917 804-0786

By Dr. Russell Blaylock, M.D.
thehnf.com
December 2009

Those who are observant have noticed a dangerous trend in the United States, as well as worldwide, and that is the resorting of various governments at different levels to mandating forced vaccination upon the public at large. My State of Mississippi has one of the most-restrictive vaccine-exemption laws in the United States, where exemptions are allowed only upon medical recommendation. Ironically, this is only on paper, as many have had as many as three physicians, some experts in neurological damage caused by vaccines, provide written calls for exemption, only to be turned down by the State’s public-health officer.

Worse are the States, such as Massachusetts, New Jersey and Maryland, where forced vaccinations have either been mandated by the courts, the state legislature, or have such legislation pending. All of such policies strongly resemble those policies found in National Socialist empires, Stalinist countries, or Communist China.

When public-health officers are asked for the legal justification for such draconian measures as forcing people to accept vaccines that they deem either a clear and present danger to themselves and their loved ones or have had personal experience with serious adverse reactions to such vaccines, they usually resort to the need to protect the public.

One quickly concludes that if the vaccines are as effective as being touted by the public-health officials, then why should one fear the unvaccinated? Obviously the vaccinated would have at least 95% protection. This question puts them in a very difficult position. Their usual response is that a “small” percentage of the vaccinated will not have sufficient protection and would still be at risk. Now, if they admit what the literature shows, that vaccine failure rates are much higher than the 5% they claim, they must face the next obvious question – then why should anyone take the vaccine if there is a significant chance it will not protect?

When pressed further, they then resort to their favorite justification, the Holy Grail of the vaccine proponents – herd immunity. This concept is based upon the idea that 95% (and some now say 100%) of the population must be vaccinated to prevent an epidemic. The percentages needing vaccination grows progressively. I pondered this question for some time before the answer hit me. Herd immunity is mostly a myth and applies only to natural immunity – that is, contracting the infection itself.

Is Herd Immunity Real?

In the original description of herd immunity, the protection to the population at large occurred only if people contracted the infections naturally. The reason for this is that naturally-acquired immunity lasts for a lifetime. The vaccine proponents quickly latched onto this concept and applied it to vaccine-induced immunity. But, there was one major problem – vaccine-induced immunity lasted for only a relatively short period, from 2 to 10 years at most, and then this applies only to humoral immunity. This is why they began, silently, to suggest boosters for most vaccines, even the common childhood infections such as chickenpox, measles, mumps, and rubella.

Then they discovered an even greater problem, the boosters were lasting for only 2 years or less. This is why we are now seeing mandates that youth entering colleges have multiple vaccines, even those which they insisted gave lifelong immunity, such as the MMR. The same is being suggested for full-grown adults. Ironically, no one in the media or medical field is asking what is going on. They just accept that it must be done.

That vaccine-induced herd immunity is mostly myth can be proven quite simply. When I was in medical school, we were taught that all of the childhood vaccines lasted a lifetime. This thinking existed for over 70 years. It was not until relatively recently that it was discovered that most of these vaccines lost their effectiveness 2 to 10 years after being given. What this means is that at least half the population, that is the baby boomers, have had no vaccine-induced immunity against any of these diseases for which they had been vaccinated very early in life. In essence, at least 50% or more of the population was unprotected for decades.

If we listen to present-day wisdom, we are all at risk of resurgent massive epidemics should the vaccination rate fall below 95%. Yet, we have all lived for at least 30 to 40 years with 50% or less of the population having vaccine protection. That is, herd immunity has not existed in this country for many decades and no resurgent epidemics have occurred. Vaccine-induced herd immunity is a lie used to frighten doctors, public-health officials, other medical personnel, and the public into accepting vaccinations.

When we examine the scientific literature, we find that for many of the vaccines protective immunity was 30 to 40%, meaning that 70% to 60% of the public has been without vaccine protection. Again, this would mean that with a 30% to 40% vaccine-effectiveness rate combined with the fact that most people lost their immune protection within 2 to 10 year of being vaccinated, most of us were without the magical 95% number needed for herd immunity. This is why vaccine defenders insist the vaccines have 95% effectiveness rates.

Without the mantra of herd immunity, these public-health officials would not be able to justify forced mass vaccinations. I usually give the physicians who question my statement that herd immunity is a myth a simple example. When I was a medical student almost 40 years ago, it was taught that the tetanus vaccine would last a lifetime. Then 30 years after it had been mandated, we discovered that its protection lasted no more than 10 years. Then, I ask my doubting physician if he or she has ever seen a case of tetanus? Most have not. I then tell them to look at the yearly data on tetanus infections – one sees no rise in tetanus cases. The same can be said for measles, mumps, and other childhood infections. It was, and still is, all a myth.

The entire case for forced mass vaccination rest upon this myth and it is important that we demonstrate the falsity of this idea. Neil Z. Miller, in his latest book The Vaccine Information Manual, provides compelling evidence that herd immunity is a myth.

The Road to Hell is Paved with Good Intentions

Those pushing mandatory vaccination for an ever-growing list of diseases are a mixed bag. Some are quite sincere and truly want to improve the health of the United States. They believe the vaccine-induced herd immunity myth and likewise believe that vaccines are basically effective and safe. These are not the evil people.

A growing number are made of those with a collectivist worldview and see themselves as a core of elite wise men and women who should tell the rest of us what we should do in all aspects of our lives. They see us as ignorant cattle, who are unable to understand the virtues of their plan for America and the World. Like children, we must be made to take our medicine – since, in their view, we have no concept of the true benefit of the bad-tasting medicine we are to be fed.

I have also found that a small number of people in the regulatory agencies and public health departments would like to speak out but are so intimidated and threatened with dismissal or destruction of their careers, that they remain silent. As for the media, they are absolutely clueless.

I have found that “reporters” (we have few real journalists these days) rarely understand what they are reporting on and always trust and rely upon people in positions of official power, even if those people are unqualified to speak on the subject. Most of the time they run to the Centers for Disease Control or medical university to seek answers. I cannot count the number of times I have seen university department heads interviewed when it was obvious they had no clue as to the subject being discussed. Few such professors will pass up an opportunity to appear on camera or be quoted in a newspaper.

One must also appreciate that such reporters and editors are under an enormous economic strain, as vaccine manufacturers are major advertisers in all media outlets and for an obvious reason – it controls content. A number of excellent stories on such medical subjects are spiked every day. That means we will always be relegated to the “fringe media” as our media outlets are called. Despite the high quality of the journalism in many of the “fringe” outlets, they have a much smaller audience. And despite this we are having an enormous effect on the debate.

As the Public Awakens, the Collectivist Becomes Desperate

John Jewkes, in his book Ordeal by Planning, observed that as the British collectivists began to see opposition rise to their grandiose plans, they became more desperate and aggressive in their reaction. They then initiated a campaign of smearing their opponents and blaming every failure on the unwillingness of the people to accept the planner’s dictates without question. We certainly have seen this in this debate -opponents to forced vaccinations are referred to as fringe scientists, kooks, uneducated, confused, and enemies of public safety – reminiscent of Stalin’s favorite phrase, “enemy of the people.”

This desperation is based upon their fear that the public might soon catch on to the fact that the entire vaccine program is based upon nonsense, fear, and concocted fairy tales. One special fear of theirs is that the public might discover the fact that most vaccines are contaminated with a number of known and yet-to-be discovered viruses, bacteria, viral fragments, and DNA/RNA fragments. And, further, that our science demonstrates that these contaminants could lead to a number of slowly-developing degenerative diseases, including degenerative diseases of the brain. This is rarely discussed but is of major importance in this debate.

The idea that adults and their children would be forced to submit to being injected with dozens of these organisms and organic fragments is terrifying. No regulatory agency is tracking to see if chronic diseases are rising in the vaccinated, yet we have compelling evidence of a massive rise in all autoimmune diseases, neurodegenerative diseases, and certain cancers since the advent of a dramatic increase in the number of vaccines being mandated.

Of special concern is the finding that many of the contaminant organisms can pass from generation to generation. For example, new studies have found that SV-40, a major contaminant of the polio vaccine until 1963, not only existed as a latent virus for the lifetime of those exposed to the vaccine but was being passed on to the next generation, primarily by way of sperm, something called vertical transmission. This means that every generation from now on will be infected with this known carcinogenic virus. There is also compelling evidence that some polio vaccines manufactured after 1963 may contain SV-40 virus.

What makes the SV-40 contamination disaster of such concern is its association with so many cancers – including mesothelioma, medulloblastoma, ependymoma, meningioma, astrocytoma, oligodendroglioma, pituitary adenoma, glioblastoma, osteosarcomas, non-Hodgkins lymphoma, papillary thyroid carcinomas, and anaplastic thyroid carcinomas.

The Federal government has gone to enormous lengths to cover up this association, despite the powerful scientific evidence that this vaccine infected at least a hundred million people worldwide with this carcinogenic virus. And, it took over 40 years just to get this far. Linking vaccine contaminations and immunoexcitotoxicity to the drastic rise in neurodegenerative diseases will probably take even longer because of the widespread growth of entrenched powers high in government and their control of the media, which is equally extensive. The fact that powerful, enormously wealthy foundations, such as the Ford Foundation, Bill and Melinda Gates Foundation, and Rockefeller series of foundations, are supporting forced vaccination greatly enhances the power of governments all over the World.

These foundations operate in the shadows, influencing legislation and government actions through the World Health Organization and individual governmental bodies. Behind every call for forced vaccinations, mandated quarantines, and home invasions, one can find one of these foundations providing the money as well as experts. Remember, the largest of the pharmaceutical-vaccine manufacturers are also providing much of the money for the foundations and serving on the boards of these foundations. The Rockefellers either owned outright or had controlling interest in all of the major pharmaceutical companies. This has given them absolute and extremely powerful access to the reins of power at all levels. Yet, they can be defeated by the truth.

Other credits include Dr. Blaylock’s DVD Nutrition & Behavior, a CD-ROM on the Truth About Aspartame, and, for the past five years, a health newsletter The Blaylock Wellness Report, published by NewsMax. Since the publication of his first book, he has been a guest on over 100 syndicated radio and television programs and appeared on the 700 Club seven times. He lectures widely to both lay and professional medical audiences on a variety of nutritional subjects.

Dr. Blaylock is a visiting professor of biology at Belhaven College and serves on the editorial staff of the Journal of the American Nutraceutical Association, the editorial staff of the Fluoride Journal and is on the editorial staff of the Journal of American Physicians and Surgeons, official journal of the Association of American Physicians and Surgeons. He is also a regular lecturer for the Fellowship for Anti-aging and Regenerative Medicine.